Metiamid je histaminski antagonist H2-receptora koji je razvijen počevši od burimamida.[3] On je bio prvo intermedijarno jedinjenje u razvoju uspešnog leka protiv čireva, cimetidina (Tagameta).[4]
^Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^Clayden, Jonathan; Greeves, Nick; Warren, Stuart; Wothers, Peter (2001). Organic Chemistry (I изд.). Oxford University Press. стр. 204—206, 586—588. ISBN978-0-19-850346-0.